Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Psychol Med. 2014 Aug 4;45(4):759–770. doi: 10.1017/S0033291714001810

Table 1. Clinical and Demographic Features.

Features Patients (N = 62) Controls (N = 41)
Mean/N (SD)
SCZ (N = 40)
Mean/N (SD)
BPP (N = 22)
Mean/N (SD)

Gender (Male/Female) 30/10 15/7 30/11
Handedness (R/L) 35/5 19/3 37/4
Age 33.5 (9.02) 34.72 (10.51) 33.24 (9.04)
Parental NS-SEC 2.47 (1.50) 1.70 (1.17) 1.97 (1.29)
Quick Test (IQ) 95.76 (13.48) 102.80 (14.59) 105.78(11.72)
Mean Illness Duration (Years) 9.92 (7.57) 10.68 (8.35) -
Number of Episodes 2.36 (1.51) 3.40 (1.69) -
DDD Antipsychotics 1.29 (1.09) 0.47 (0.59) -
DDD Mood Stabilizers 0.06 (0.24) 0.91 (0.63) -
DDD Antidepressants 0.32 (0.66) 0.07 (0.32) -
DDD (all psychotropics) 1.67 (1.33) 1.46 (0.97) -
SOFAS Score 53.75 (12.32) 61.04 (13.14) -
Reality Distortion 2.50 (2.62) 0.57 (1.46) -
Psychomotor Poverty 2.80 (3.48) 0.42 (1.20) -
Disorganization 1.57 (1.87) 1.14 (1.98) -
Anxiety/Depression 2.05 (1.99) 1.23 (1.48) -
Psychomotor Excitation 1.15 (1.33) 3.23 (3.44) -
SSPI Total Score 11.5 (7.53) 8.57 (8.12) -

NS-SEC: National Statistics Socio-Economic Classification; SSPI: Signs and Symptoms of Psychotic Illness; DDD: Defined Daily Dose; SOFAS: Social and Occupational Functioning Assessment Scale.